glaucoma

Helping patients better understand glaucomaWhen I was a resident at the SUNY College of Optometry, I was asked a to conduct a few patient question and answer sessions regarding glaucoma. The sessions consisted of me sitting with a small group of patients, family members, or whoever wanted to know more about glaucoma.
Implementing myopia prevention and controlMyopia control and prevention has become a popular topic due to more data on myopia becoming available.
Updated hand-held tonometer enhances clinical experienceA newly released hand-held tonometer model (Icare ic100, Icare U.S.A.) features several design upgrades while retaining the rebound technology for measuring IOP that was at the core of the earlier model.
Tools ODs can utilize to diagnose, treat glaucomaODs must have the right tools in their toolboxes when treating glaucoma correctly, says Optometry Times board member Michael Chaglasian, OD, FAAO, at Vision Expo East in New York.
Patients’ health jeopardized by failed ophthalmology follow-upFailure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.
Non-invasive punctal plug delivery system offers a host of positive performance characteristics
Non-invasive punctal plug delivery system offers a host of positive performance characteristicsA silicone punctal plug-based delivery system for ophthalmic medications (Evolute, Mati Therapeutics) provides precisely controlled medication release into the tear film and has been associated with positive results in initial clinical testing.
Bimatoprost insert offers noninvasive platform for early glaucoma patients A 19-month, open-label study of a novel bimatoprost, sustained-release ocular insert shows good safety and efficacy. The insert is polymer ring that sits atop the eye in the conjunctival fornix. Phase III trials are expected to begin in 2017.
Stem cells offering faint cure possibility for glaucomaStem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference.
Autoantibodies may serve as glaucoma biomarkersThe loss of autoantibodies may serve as useful biomarkers for glaucoma, according to Nadine von Thun Und Hohenstein-Blaul, Johannes Gutenberg University Mainz, Mainz, Germany, and colleagues.
Irritation in a bottle: Glaucoma and OSDOSD is of significant concern in patients with glaucoma on multiple topical medications. Optimal treatment of this condition with minimizing the intensity as well as with additional pharmacologic treatments for OSD can improve visual acuity and compliance and result in better outcomes both medically and regarding patient satisfaction.